Skip to main content

Research Pathways

Bringing gene and cell therapies from the lab bench to patients is a complex process and multiple pathways exists. The Research Pathways directory contains resources to help various stakeholders interested in therapy development navigate this process. Research Pathways is centred around the legal and regulatory aspects for cell and gene therapy development in Europe and further expanded to additional aspects. It is free to use and all resources in this database are categorised for improved searchability.

How to use Research Pathways  EuroGCT's Key Resources

Additional navigation options

More ways to navigate Research Pathways

Showing 2 of 2
EuroGCT Resource

MTI et médicaments orphelins

  • EU and UK
  • 2023
  • EuroGCT
Advanced therapy medicinal products (ATMPs) and orphan medicinal products. Obtaining the orphan designation gives access to financial and regulatory incentives aimed at improving the attractivity of research and development of innovative medicinal products for rare diseases. 

Theme

  • Tout afficher 2
  • Therapy classification
  • ATMPs
EuroGCT Resource

Therapy Classification

  • EU and UK
  • 2022
  • EuroGCT
Therapy classification determines the legal mechanisms that govern the regulation of gene and cell therapies to ensure the quality, safety, and efficacy of these therapies on the EU market.

Theme

  • Tout afficher 5
  • Therapy classification
  • Legal classification
  • ATMPs
  • Not ATMPs: Human body elements for therapeutic applications
  • Not ATMPs: medical devices containing tissues and cells
Le contenu de cette page vous a-t-il été utile ? Envoyez-nous vos commentaires